Sale!

ANLN Gene Focal Segmental Glomerulosclerosis Type 8 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “ANLN Gene Focal Segmental Glomerulosclerosis Type 8 Genetic Test” is a specialized diagnostic tool designed to identify mutations in the ANLN gene, which are associated with Focal Segmental Glomerulosclerosis Type 8 (FSGS8). FSGS8 is a rare form of kidney disease that affects the glomeruli, the filtering units of the kidney, leading to proteinuria, nephrotic syndrome, and potentially chronic kidney disease. Early and accurate diagnosis through genetic testing can be crucial in managing and treating the condition effectively.

This test is available at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the test is 4400 AED, reflecting the intricate technology and expertise required to accurately identify the specific genetic mutations of the ANLN gene associated with FSGS8. By opting for this test, patients and healthcare providers can gain valuable insights into the genetic underpinnings of the condition, enabling tailored treatment plans and potentially improving patient outcomes.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ANLN Gene Focal segmental glomerulosclerosis type 8 Genetic Test

At DNA Labs UAE, we offer the ANLN Gene Focal segmental glomerulosclerosis type 8 Genetic Test. This test is designed to diagnose and identify genetic variations associated with Focal Segmental Glomerulosclerosis (FSGS) type 8, a rare genetic disorder that affects the kidneys.

Test Components and Price

The ANLN Gene Focal segmental glomerulosclerosis type 8 Genetic Test is priced at 4400.0 AED. The test requires a blood sample, extracted DNA, or one drop of blood on an FTA card.

Report Delivery and Method

After the sample is collected, the report will be delivered within 3 to 4 weeks. The test utilizes NGS (Next-Generation Sequencing) technology to analyze the DNA sequence and identify any genetic variations or mutations associated with FSGS type 8.

Test Type and Doctor

The ANLN Gene Focal segmental glomerulosclerosis type 8 Genetic Test falls under the category of Hepatology, Nephrology, and Endocrinology Disorders. It is recommended to consult with a General Physician for this test.

Test Department and Pre Test Information

This test is conducted in the Genetics department. Before taking the test, it is essential to provide the clinical history of the patient who is going for the ANLN Gene Focal segmental glomerulosclerosis type 8 NGS Genetic DNA Test. A Genetic Counselling session will be conducted to draw a pedigree chart of family members affected by the ANLN Gene.

About FSGS Type 8 and NGS Genetic Testing

Focal Segmental Glomerulosclerosis (FSGS) type 8 is a condition characterized by scarring and damage to the glomeruli, the tiny blood vessels in the kidneys responsible for filtering waste and excess fluid from the blood. The ANLN gene is associated with this condition.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze a person’s DNA sequence and identify genetic variations or mutations associated with specific conditions. In the case of FSGS type 8, NGS genetic testing can identify mutations or variations in the ANLN gene that may contribute to the development of the condition.

By identifying these genetic variations, healthcare providers can make an accurate diagnosis of FSGS type 8 and provide appropriate treatment and management strategies. NGS genetic testing also plays a crucial role in genetic counseling and family planning, as it helps determine the risk of passing on the condition to future generations.

Test Name ANLN Gene Focal segmental glomerulosclerosis type 8 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Hepatology Nephrology Endocrinology Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for ANLN Gene Focal segmental glomerulosclerosis type 8 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ANLN Gene Focal segmental glomerulosclerosis type 8 NGS Genetic DNA Test gene ANLN
Test Details

The ANLN gene is associated with Focal Segmental Glomerulosclerosis (FSGS) type 8, which is a rare genetic disorder that affects the kidneys. FSGS is a condition characterized by scarring and damage to the glomeruli, which are the tiny blood vessels in the kidneys responsible for filtering waste and excess fluid from the blood.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze a person’s DNA sequence and identify any genetic variations or mutations that may be associated with a particular condition. In the case of FSGS type 8, NGS genetic testing can be used to identify mutations or variations in the ANLN gene that may be responsible for the development of the condition.

By identifying these genetic variations, healthcare providers can make an accurate diagnosis of FSGS type 8 and provide appropriate treatment and management strategies for affected individuals. NGS genetic testing can also be used for genetic counseling and family planning purposes, as it can help determine the risk of passing on the condition to future generations.